PCDHGB7 and cancer: Specifically, the cancer universality of PCDHGB7 and TAGMe hypermethylation was demonstrated by the statistically significant differences generally found in malignant and nonmalignant samples from patients with different cancer types (Supplemental Figure 3, B and C).